HomeNDC LookupIngredientsSalicylic Acid › 85384-0016-01
TAGRID TINEA VERSICOLOR Salicylic Acid 2 g/100g Cream, 95.83 g — NDC 85384-0016-01 package photo

TAGRID TINEA VERSICOLOR Salicylic Acid 2 g/100g Cream, 95.83 g

by TAGRID LLC · 95.83 g in 1 CAN (85384-0016-1)
NDC 85384-0016-01
🏷️ FDA NDC (as labeled) 85384-0016-1 billing pads the package segment with a zero
OTC On market Non-controlled
🗂️ Data synced Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

🆔 Identity & classification

FDA NDC (as labeled) 85384-0016-1
Product NDC 85384-0016
11-digit billing NDC 85384001601
UNII O414PZ4LPZ
Application # M016
SPL Set ID b3f6fc16-4d5e-4178-863e-c3b3db95a99d
DEA schedule Non-controlled
Marketing category OTC MONOGRAPH DRUG
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2025-07-19
Route TOPICAL
Dosage form CREAM
Substance SALICYLIC ACID
Why two NDCs? The FDA registers this code as 85384-0016-1 — a 5-4-1 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the package segment → 85384-0016-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

🏭 Manufacturer & labeler

LabelerTAGRID LLC
FDA applicationM016 (OTC MONOGRAPH DRUG)
Labeler code85384
First marketedJul 2025
Product typeHuman Otc Drug
Portfolio24 products on file
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

🩺 Clinical

🧪 What is this product?

Tagrid Tinea Versicolor is a topical cream containing salicylic acid at a concentration of 2 grams per 100 grams. This is an over-the-counter monograph drug, meaning it is marketed under FDA's established rules for this category of products. Salicylic acid is commonly used in skin care products to help soften and remove the outer layer of skin and is typically found in treatments for various skin conditions. The product is applied directly to the skin.

Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

🧪 Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

💡 Tap an ingredient (hover on desktop) to see what it is and why it’s used.

  • UNII 32MP823R8S
    A plant-derived ingredient from mugwort root, used in traditional herbal formulations. It may function as a flavoring agent, botanical extract, or natural additive in the medicine.
  • UNII 04W97Z676Y
    A plant-derived natural substance from Bassia scoparia fruit used as a glidant and anti-caking agent. It helps powder ingredients flow smoothly and prevents clumping in the tablet or capsule.
  • UNII 6153LEN214
    A plant extract from the root of Dictamnus dasycarpus, used in some formulations as a natural flavoring agent, fragrance component, or traditional botanical ingredient to enhance taste or aroma.
  • UNII R4DRG4762Y
    A plant-derived ingredient from the root of Euphorbia fischeriana. It may serve as a binder or thickening agent to help hold the medicine's ingredients together and improve texture.
  • UNII A6W0J6UO7Q
    A plant-derived extract from the fruit of the Chinese honey locust tree. It serves as a natural thickener and emulsifier to help blend ingredients and create a smooth, uniform texture in medicines.
  • UNII PBG27B754G
    Phellodendron amurense bark is a plant-derived ingredient from the cork tree. It functions as a natural preservative and antimicrobial agent to help maintain product stability and prevent microbial growth.
  • UNII PES3YXA3LR
    A plant extract from the smilax glabra tuber root. It may be used as a natural flavoring agent or traditional herbal ingredient to enhance taste or provide botanical character to the medicine.
  • UNII 6M6NP03LMK
    Solidago decurrens fruiting top is a plant-derived ingredient from goldenrod. It's used in herbal formulations as a traditional botanical component to support the product's intended properties.
  • UNII 7S9328671Z
    A plant extract from stemona tuberosa root used as a natural preservative and antimicrobial agent in some formulations to help prevent spoilage and extend shelf life.
  • UNII 059QF0KO0R
    Water is a liquid solvent that dissolves and mixes ingredients together in liquid medicines, syrups, and injections. It helps distribute the active drug evenly throughout the product.

10 inactive ingredients listed in the exact product block matched to this NDC.

The official label also statesInactive ingredients: Water Artemisia vulgaris extract Kochia scoparia fruit extract Dictamnus dasycarpus root extract Smilax glabra root extract Solidago decurrens fruiting top extract Phellodendron amurense bark extract Euphorbia fischeriana root extract Gleditsia sinensis fruit extract Stemona tuberosa root extract

Label-section wording can be broader than the structured product block and may mention additional formulation ingredients.

Where does this data come from?
Data sourced from official FDA Structured Product Labeling (SPL) via DailyMedingredient classCode="IACT" elements from the exact product block matched by this NDC. Label-section narrative from DailyMed / the openFDA label index is shown separately when available.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

💲 Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer gPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

🔁 Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Nas Max Strength Spot Treatment 2 g/100g 26052-0022-01 BURT'S 1 tube FDA listed
Salicylic Acid 2 g/100g 71819-0003-04 D3 113 g FDA listed
Asepxia Charcoal Acne Bar 2 g/100g 50066-0801-01 Genomma 1 applicator FDA listed
Asepxia Neutral Acne Bar 2 g/100g 50066-0802-01 Genomma 1 applicator FDA listed
Asepxia Oil-Free Acne Bar 2 g/100g 50066-0803-01 Genomma 1 applicator FDA listed
Asepxia Scrub Acne Bar 2 g/100g 50066-0804-01 Genomma 1 applicator FDA listed
Asepxia Softening Acne Bar 2 g/100g 50066-0805-01 Genomma 1 applicator FDA listed
Tingl Exfoliating Pads 2 g/100g 83286-0011-01 Drmtlgy, 60 patches FDA listed
Perricone MD Acne Relief Maximum Strength Spot Gel 2 g/100g 84448-0538-14 THG 1 tube FDA listed
Alba Natural Acnedote Astringent 2 g/100g 61995-2753-06 The 177 g FDA listed
PCA SKIN Intensive Clarity Treatment 2 g/100g 68726-0359-02 CP 1 tube FDA listed
Clear Proof Clarifying Cleansing Gel Acne Medication 2 g/100g 51531-1349-01 Mary 28 g FDA listed
Spot Acne Treatment Oil Free 0.75oz 2 g/100g 57337-0168-01 Rejoice 21 g FDA listed
Blemish Control Bar 2 g/100g 68726-0439-01 CP 1 jar FDA listed
AL00761 Alba Botanica Acnedote Face and Body Scrub 2 g/100g 61995-3761-09 The 227 g FDA listed
Acne Warrior Body Scrub 2 g/100g 61197-0410-00 Pacifica 170 g FDA listed
Zapzyt Acne Wash Cleanser 2 g/100g 71687-0007-01 Focus 188.5 g FDA listed
Proven Acne Cleanser 2 g/100g 73572-0011-01 Proven 50 g FDA listed
Kenkoderm Psoriasis Moisturizing 2 g/100g 85286-0004-01 Nexgel,Inc. 295 g FDA listed
Acne Defense Spot Treatment Merle Norman 2 g/100g 57627-0201-02 Merle 1 tube FDA listed
Clarifying Cleanser 2 g/100g 72957-0011-01 Private 203 g FDA listed
Proven Acne Cleanser 2 g/100g 73572-0010-01 Proven 50 g FDA listed
Tagrid Tinea Versicolor 2 g/100gthis 85384-0016-01 TAGRID 95.83 g FDA listed
Advanced DermaClear Serum 2 g/100g 62742-4280-02 Allure 1 bottle FDA listed
Shaant Hydrating Body Scrub 2 g/100g 83196-0785-12 Codex 1 tube FDA listed
Acne Treatment Maximum Strength 2 g/100g 70631-0358-02 Young 1 tube FDA listed
Kenkoderm Psoriasis Moisturizing 2 g/100g 73632-0004-01 Olympus 295 g FDA listed
Shaant Pore Purifying Face Scrub 2 g/100g 83196-0676-12 Codex 1 tube FDA listed
ES Salicylic Wash 2 g/100g 87702-0141-01 Elaine 200 g FDA listed
AL0076001 Alba Botanica Acnedote Deep Pore Wash 2 g/100g 61995-2060-06 The 177 g FDA listed
Soraresal 2 g/100g 73526-0002-02 Summer 1 bottle FDA listed
Orlaskin Salicylic Acid Acne Treatment Pads 2 g/100g 87582-0006-01 Guangzhou 80 patches FDA listed
PCA Skin Acne Control Prebiotic Cleanser 2 g/100g 68726-0607-02 CP 1 bottle FDA listed
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2025
On the market since
Jul 2025
📍
2026
Currently FDA-listed
1 year listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

📊 Medicare Part D spend CMS · PART D · 2026 (Q1)

Medicare Part D (outpatient prescription) spending for Salicylic Acid (matched by generic name) — the program that covers self-administered drugs. 2 manufacturers.
⚠️ Drug-level data: CMS publishes Part D spending by drug, not by NDC — these figures combine every manufacturer, strength and package size sold under the name Salicylic Acid. That’s a different level of aggregation than the Medicaid card above, which is specific to this exact 11-digit NDC (pack size included), so the two aren’t directly comparable.
Period
Total Part D spend
$11.2K
Claims incl. refills
43
Beneficiaries
35
Spend / beneficiary
$319.01
Spend / claim
$259.66
Trend by period
💵 About the dollar figures: spending is what Part D plans paid before confidential manufacturer rebates, so the program’s real net cost is lower. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part D Spending by Drug (data.cms.gov), updated quarterly.

🔬 Reported adverse events (FAERS)

Read carefully: FAERS reports are voluntary and unverified. Counts are not incidence, do not establish causation, are subject to reporting bias, and cannot be used to compare one drug to another. Shown for signal context only. Reports for TAGRID TINEA VERSICOLOR (this brand).

Top reported reactions

Vomiting216
Pruritus205
Weight Decreased188
Condition Aggravated184
Urticaria184
Weight Increased183
Hypertension181

Age at onset

Neonate7
Infant1
Child8
Adolescent5
Adult170
Elderly94

Reporter sex

1,853 reports
Male · 37%
Female · 63%
Unknown · 0%

Serious outcomes

Hospitalization623
Life-threatening174
Reports over time (by year) — tap or hover for the count & year
2023 2024 2025 2026 252 93
Most recent year is provisional (FAERS lags ~3 months).
Where does this data come from?
Adverse-event reports from the FDA Adverse Event Reporting System (FAERS) via openFDA. FAERS reports are voluntary and unverified — counts are not incidence and don’t establish causation.

📦 Packaging — all sizes for this product

Package NDCDescription Marketing startStatus
85384-0016-01 You're viewing this 95.83 g in 1 CAN (85384-0016-1) 2025-07-19 Active

🧭 About this NDC listing & data coverage

Over-the-counter (OTC) product
What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) ✓ Available
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Otc Monograph Drug". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The FDA registers it as 85384-0016-1, which is what is printed on the packaging and shown on DailyMed. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero: 85384-0016-01, written without dashes as 85384001601. The Identity section at the top of this page lists every form of this code.
What do the three segments of this NDC mean?
In 85384-0016-01, the first segment (85384) is the labeler code FDA assigned to TAGRID LLC; the middle segment (0016) identifies this specific product — its ingredient, strength, and dosage form; and the last segment (01) identifies this exact package size and type. Together they name one specific package of one specific product.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by TAGRID LLC. Listing status can change — the directory data on this page refreshes weekly.
Who lists this product with the FDA?
TAGRID LLC is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.

📄 FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage 14 words

Uses: Treats tinea versicolor (a skin condition that causes discolored patches) Helps prevent recurrence

⏱️ Dosage and Administration 35 words

Directions: Wash the affected area with warm water and dry thoroughly. Apply a small amount to the affected area 2–3 times daily. Continue use for at least one week after symptoms disappear to prevent recurrence.

⚠️ Warnings 87 words

For external use only Do not use: on children under 2 years of age unless directed by a doctor near eyes or mucous membranes When using this product avoid contact with eyes. If contact occurs, rinse thoroughly with water. if irritation or rash develops, stop use and consult a doctor. Stop use and ask a doctor if If irritation or rash develops, stop use and consult a doctor.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

🧪 Active Ingredient 5 words

Active ingredient: Salicylic Acid 2%

🧪 Inactive Ingredients 39 words

Inactive ingredients: Water Artemisia vulgaris extract Kochia scoparia fruit extract Dictamnus dasycarpus root extract Smilax glabra root extract Solidago decurrens fruiting top extract Phellodendron amurense bark extract Euphorbia fischeriana root extract Gleditsia sinensis fruit extract Stemona tuberosa root extract

🎯 Purpose 1 words

Antifungal

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.